首页> 外文期刊>Trials >Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: The EQUIP-ACS project protocol and design
【24h】

Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: The EQUIP-ACS project protocol and design

机译:改善非ST段抬高急性冠状动脉综合征的管理:质量改善计划的系统评估欧洲急性冠脉综合征的质量改善计划:EQUIP-ACS项目方案和设计

获取原文
       

摘要

Background Acute coronary syndromes, including myocardial infarction and unstable angina, are important causes of premature mortality, morbidity and hospital admissions. Acute coronary syndromes consume large amounts of health care resources, and have a major negative economic and social impact through days lost at work, support for disability, and coping with the psychological consequences of illness. Several registries have shown that evidence based treatments are under-utilised in this patient population, particularly in high-risk patients. There is evidence that systematic educational programmes can lead to improvement in the management of these patients. Since application of the results of important clinical trials and expert clinical guidelines into clinical practice leads to improved patient care and outcomes, we propose to test a quality improvement programme in a general group of hospitals in Europe. Methods/Design This will be a multi-centre cluster-randomised study in 5 European countries: France, Spain, Poland, Italy and the UK. Thirty eight hospitals will be randomised to receive a quality improvement programme or no quality improvement programme. Centres will enter data for all eligible non-ST segment elevation acute coronary syndrome patients admitted to their hospital for a period of approximately 10 months onto the study database and the sample size is estimated at 2,000-4,000 patients. The primary outcome is a composite of eight measures to assess aggregate potential for improvement in the management and treatment of this patient population (risk stratification, early coronary angiography, anticoagulation, beta-blockers, statins, ACE-inhibitors, clopidogrel as a loading dose and at discharge). After the quality improvement programme, each of the eight measures will be compared between the two groups, correcting for cluster effect. Discussion If we can demonstrate important improvements in the quality of patient care as a result of a quality improvement programme, this could lead to a greater acceptance that such programmes should be incorporated into routine health training for health professionals and hospital managers. Trial registration Clinicaltrials.gov NCT00716430
机译:背景技术急性冠状动脉综合征,包括心肌梗塞和不稳定型心绞痛,是过早死亡,发病率和入院率的重要原因。急性冠状动脉综合征消耗大量的医疗资源,并通过在工作中损失几天的时间,对残疾的支持以及应对疾病的心理后果而对经济和社会产生重大的负面影响。几个注册表显示,在这种患者人群中,尤其是在高危患者中,基于证据的治疗未得到充分利用。有证据表明,系统的教育计划可以改善这些患者的管理。由于将重要的临床试验结果和专家临床指南的结果应用到临床实践中可以改善患者的护理和治疗效果,因此,我们建议在欧洲的一般医院中测试质量改进计划。方法/设计这是一项在5个欧洲国家(法国,西班牙,波兰,意大利和英国)的多中心集群随机研究。 38家医院将被随机分配接受质量改进计划或不接受质量改进计划。中心将在研究数据库中输入入院约10个月的所有合格非ST段抬高的急性冠状动脉综合症患者的数据,样本量估计为2,000-4,000名患者。主要结果是八项措施的综合评估,以评估改善该患者群体的管理和治疗的总体潜力(风险分层,早期冠状动脉造影,抗凝,β受体阻滞剂,他汀类药物,ACE抑制剂,氯吡格雷作为负荷剂量和在放电时)。在实施质量改进计划之后,将对两组中的八项措施中的每一项进行比较,以校正集群效应。讨论如果我们可以通过质量改进计划证明患者护理质量的重要改善,那么这可能会导致人们更加接受这样的计划应该纳入针对卫生专业人员和医院管理人员的常规健康培训中。试用注册Clinicaltrials.gov NCT00716430

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号